ORLOBIN 500MG/2ML VIAL

  • اسم المستحضر : ORLOBIN 500MG/2ML VIAL
  • اسم المصنع : Helps S.A./Greece
  • التصنيف : Import Product
  • الوكيل / الموزع : Medimarket Drug Store
  • الشكل الصيدلاني : Solution for injection (IM or IV)
  • المكونات الفعالة : Each1ml contains: Amikacin (as sulfate) 250mg
  • يستخدم لـ : Indicated in the short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria (including Pseudomonas sp, Escherichia coli., indole-positive and indole-negative Proteus pp., Providencia sp, Klebsiella sp, Enterobacter sp, Serratia sp and Acinetobacter sp.). Clinical studies have shown amikacin injection to be effective in bacteremia and septicemia (including neonatal sepsis), in serious infections of the respiratory tract, bones and joints, central nervous system (including meningitis), skin and soft tissue, intra-abdominal infections (including peritonitis), in burns and postoperative infections (including post-vascular surgery). Clinical studies have shown amikacin also to be effective in serious complicated and recurrent urinary system infections due to those organisms. Aminoglycosides, including amikacin are not indicated in uncomplicated initial episodes of urinary system infections unless the causative microorganisms are not susceptible to antibiotics having less potential toxicity. When amikacin is indicated in the therapy of uncomplicated urinary system infections, reduced dosage may be prescribed. Microbiological tests should be performed to identify causative microorganisms and their susceptibilities to amikacin. Amikacin may be used as initial therapy in infections attributed to Gram-negative microorganisms and initiation of therapy may occur before obtaining the results of susceptibility testing. Clinical trials demonstrated that amikacin is effective in infections caused by gentamicin and/or tobramycin resistant strains of Gram-negative microorganisms, particularly Proteus rettgeri, Providencia stuartii, Serratia marcescens, and Pseudomonas aeruginosa. The decision to continue therapy with the drug should be based on results of the susceptibility tests, the severity of the infection, the response of the patient, as well as any important additional data taken into consideration by the doctor. Amikacin has also been shown to be effective in staphylococci infections and may be considered as initial therapy under certain conditions in the treatment of known or suspected staphylococcal infections such as: severe infections where the causative microorganism may be either a Gram-negative bacterium or a staphylococcus, infections due to susceptible strains of staphylococci in patients allergic to other antibiotics and in mixed infections due to staphylococcus and Gram-negative microorganism. In certain severe infections such as neonatal sepsis, concomitant therapy with a penicillin-type drug may be indicated because there is the possibility of infections due to Gram-positive microorganisms such as streptococci or pneumococci. Formal instructions for the appropriate use of antimicrobial medicines must be taken into consideration.
  • رقم التسجيل : 328/6775/02
  • تاريخ التسجيل : 09-05-2019
  • تاريخ انتهاء التسجيل : 09-05-2024

Please Wait